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INTRODUCTION 
Psoriasis is a common dermatological condition affecting ski, joints, nails and other 
systems. It is a psychocutaneous disorder in which there is complex interaction 
between skin and mind. Approximately 30 – 40% of patients seeking medical 
treatment for their skin conditions, often have an underlying psychological problem or 
psychiatric illness that causes or exacerbates the skin disorders. The prevalence of 
depression and anxiety in those with psoriasis is higher and the quality of life is low. 
If these co morbidities are not treated, they influence the treatment improvement of 
primary dermatological condition. 
MATERIALS AND METHODS 
100 Patients with psoriasis were included in the study based on selection criteria. The 
prevalence and severity of depression and anxiety, their quality of life and its 
influence on severity of psoriasis was assessed using scales HAM-D, HAM –A, 
DQLI, BPRS. 
RESULTS 
The overall prevalence of depression and anxiety was 43 % and 20% respectively. 
Among them 84 % had poor quality of life, patients with higher severity of psoriasis 
and psychiatric morbidity had poor quality of life. 
CONCLUSION 
Psoriasis could result in impairment of social and occupational domains. Depression 
in these patients go unnoticed and could even result in suicide attempts. Patients, 
including their families have to be educated regarding the illness, and the need for 
psychiatric consultation, since psychiatric morbidity could exacerbate psoriasis and 
also influence the treatment adherence. Timely intervention of psychiatric morbidity 
will improve the patient’s condition and thereby the quality of life. 
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